Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-060785

LIGAND PHARMACEUTICALS INC · LGND

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Aug 17, 2015
Accepted (ET)
Aug 19, 2015 · 6:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000886163

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 17, 2015S4,000$95.9843D66,152D
Common StockF1,F3holding———969,300IBy Knott Partners, L.P.
Common StockF1,F3holding———196,186IBy Shoshone Partners, L.P.
Common StockF1,F3holding———30,771IBy Knott Partners Offshore Master Fund, L.P.
Common StockF2,F3holding———1,666IBy Managed Account C
Common StockF2,F3holding———1,843IBy immediate family member

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses